Pacific Biosciences Of California (PACB) EPS (Basic) Growth (5y) (2015 - 2026)
Pacific Biosciences Of California (PACB) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.59 Bn | 193.99 Bn | 7.27 Bn |
| 2 | Stryker | 126.90 Bn | 123.42 Bn | 4.50 Bn |
| 3 | Medtronic | 118.28 Bn | 109.06 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.95 Bn | 72.41 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.59 Bn | 47.34 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.64 Bn | 31.53 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.08 Bn | 22.76 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Pacific Biosciences Of California | 383.66 Mn | 146.79 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.17% |
| Mar 31, 2026 | 32.65% |
| Dec 31, 2025 | -18.09% |
| Sep 30, 2025 | 75.47% |
| Jun 30, 2025 | 80.74% |
| Mar 31, 2025 | -45.62% |
| Dec 31, 2024 | 15.64% |
| Sep 30, 2024 | -3.42% |
| Jun 30, 2024 | -31.18% |
| Mar 31, 2024 | -6.56% |
| Dec 31, 2023 | -6.93% |
| Sep 30, 2023 | 11.12% |
| Jun 30, 2023 | -4.73% |
| Mar 31, 2023 | 6.56% |
| Dec 31, 2022 | -13.43% |
| Sep 30, 2022 | -6.70% |
| Jun 30, 2022 | 0.44% |
| Mar 31, 2022 | 13.41% |
| Dec 31, 2021 | -11.87% |
| Jun 30, 2021 | -15.72% |